- Home
- SGMO vs PDEX Comparison
SGMO vs PDEX Comparison
Compare SGMO & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- PDEX
- Stock Information
- Founded
- SGMO 1995
- PDEX 1978
- Country
- SGMO United States
- PDEX United States
- Employees
- SGMO N/A
- PDEX N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- PDEX Medical/Dental Instruments
- Sector
- SGMO Health Care
- PDEX Health Care
- Exchange
- SGMO Nasdaq
- PDEX Nasdaq
- Market Cap
- SGMO 180.5M
- PDEX 161.1M
- IPO Year
- SGMO 2000
- PDEX N/A
- Fundamental
- Price
- SGMO $2.51
- PDEX $48.56
- Analyst Decision
- SGMO Buy
- PDEX Strong Buy
- Analyst Count
- SGMO 3
- PDEX 1
- Target Price
- SGMO $7.00
- PDEX $52.00
- AVG Volume (30 Days)
- SGMO 7.3M
- PDEX 36.8K
- Earning Date
- SGMO 11-12-2024
- PDEX 02-06-2025
- Dividend Yield
- SGMO N/A
- PDEX N/A
- EPS Growth
- SGMO N/A
- PDEX 1.56
- EPS
- SGMO N/A
- PDEX 1.49
- Revenue
- SGMO $52,291,000.00
- PDEX $56,798,000.00
- Revenue This Year
- SGMO N/A
- PDEX $15.56
- Revenue Next Year
- SGMO $11.46
- PDEX $3.28
- P/E Ratio
- SGMO N/A
- PDEX $32.78
- Revenue Growth
- SGMO N/A
- PDEX 21.01
- 52 Week Low
- SGMO $0.30
- PDEX $16.18
- 52 Week High
- SGMO $3.18
- PDEX $54.84
- Technical
- Relative Strength Index (RSI)
- SGMO 55.54
- PDEX 49.20
- Support Level
- SGMO $2.24
- PDEX $45.00
- Resistance Level
- SGMO $2.82
- PDEX $49.68
- Average True Range (ATR)
- SGMO 0.28
- PDEX 3.48
- MACD
- SGMO 0.02
- PDEX -1.10
- Stochastic Oscillator
- SGMO 52.88
- PDEX 13.72
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.